본문 바로가기
KERD
논문KCI 등재

일차성 사구체신염의 육미지황탕과 양약 병용요법에 대한 체계적 문헌고찰 및 메타분석

The Effect of Combination Therapy of Yukmijihwang-tang and Western Medicine on Primary Glomerulonephritis: Systemic Review and Meta-analysis

김예슬|김경민|허태영
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2023.03|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제44권 제1호|pp. 12-34

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

meta-analysisYukmijihwang-tangprimary glomerulonephritisLiuwei Dihuang
주제분류한의학

초록

Objective: This study was conducted to evaluate the effectiveness of the combination therapy of Yukmijihwang-tang and Western medicine on primary glomerulonephritis. Methods: We conducted a search using keywords, such as Yukmijihwang-tang and Liuwei Dihuang, in eight databases (CNKI, CiNii, Pubmed, Embase, Cochrane, Science On, OASIS, RISS). There was no limit to the publication period of the papers. A meta-analysis was conducted and classified according to the outcome measurements, such as the total effective rate (TER), serum creatinine (SCr), and blood urea nitrogen (BUN). Data analysis was performed using the RevMan 5.4.1 software, and Cochrane’s risk of bias (ROB) was used to assess the quality of the papers. Results: A total of 12 randomized control trials were selected. The meta-analysis showed that the treatment group combining Yumijihwang-tang and Western medicine was more efficient than the control group using Western medicine alone (RR: 1.29, CI: 1.20 to 1.39 p=<0.00001). The treatment group also reduced the BUN (MD: -2.40, CI: -2.90 to -1.89, p<0.00001) and Scr (MD: -33.34, CI: -40.85 to -25.82, P<0.00001) more than the control group. Conclusion: This study suggests that the combination therapy of Yukmijihwang-tang with Western medicine is effective in treating primary glomerulonephritis. However, these findings should be interpreted cautiously due to the unknown or high risk of bias in the included trials.

Abstract

Objective: This study was conducted to evaluate the effectiveness of the combination therapy of Yukmijihwang-tang and Western medicine on primary glomerulonephritis. Methods: We conducted a search using keywords, such as Yukmijihwang-tang and Liuwei Dihuang, in eight databases (CNKI, CiNii, Pubmed, Embase, Cochrane, Science On, OASIS, RISS). There was no limit to the publication period of the papers. A meta-analysis was conducted and classified according to the outcome measurements, such as the total effective rate (TER), serum creatinine (SCr), and blood urea nitrogen (BUN). Data analysis was performed using the RevMan 5.4.1 software, and Cochrane’s risk of bias (ROB) was used to assess the quality of the papers. Results: A total of 12 randomized control trials were selected. The meta-analysis showed that the treatment group combining Yumijihwang-tang and Western medicine was more efficient than the control group using Western medicine alone (RR: 1.29, CI: 1.20 to 1.39 p=<0.00001). The treatment group also reduced the BUN (MD: -2.40, CI: -2.90 to -1.89, p<0.00001) and Scr (MD: -33.34, CI: -40.85 to -25.82, P<0.00001) more than the control group. Conclusion: This study suggests that the combination therapy of Yukmijihwang-tang with Western medicine is effective in treating primary glomerulonephritis. However, these findings should be interpreted cautiously due to the unknown or high risk of bias in the included trials.

참고문헌 (46)

  1. Sethi S, "Standardized classification and reporting of glomerulonephritis", Nephrol Dial Transplant, 34(2), pp.193~199 (2019)
  2. McGrogan A, "The incidence of primary glomerulonephritis worldwide : a systematic review of the literature", Nephrol Dial Transplant, 26(2), pp.414~430 (2011)
  3. 조영일, "일차성 사구체신염의 진단", 대한내과학회지, 84(1), pp.6~12 (2013), 대한내과학회[DOI]
  4. 채동완, "일차성 사구체신염의 국내발병 현황", 대한내과학회지, 84(1), pp.1~5 (2013), 대한내과학회[DOI]
  5. Yamagata K, "Age distribution and yearly changes in the incidence of ESRD in Japan", Am J Kidney Dis, 43(3), pp.433~443 (2004)
  6. Yang WC, "Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance", Nephrol Dial Transplant, 23(12), pp.3977~3982 (2008)
  7. Floege J, "Primary glomerulonephritides", Lancet, 387(10032), pp.2036~2048 (2016)
  8. 임천규, "일차성 사구체신염의 치료", 대한내과학회지, 84(1), pp.13~18 (2013), 대한내과학회[DOI]
  9. Du HK, "The approach of oriental medicine to glomerular nephritis", K.H.M, 1(18), pp.16~21 (2002)
  10. 백유상, "『小兒藥證直訣』의 五臟辨證에 대한 小考 - 病證과 處方을 중심으로 -", 대한한의학원전학회지, 24(6), pp.145~167 (2011), 대한한의학원전학회
  11. Kim SS, "Pharmacology", pp.298~300 (1999), YeongLimsa
  12. Cai HF, "Effect of Liuwei Dihuang Wan on Renal Function in 5", 6 Nephrectmized Rat, 2007, pp.27(2), 17~19
  13. Dong FX, "The clinical research on serum cystatin-C alteration on stage II chronic kidney disease with gubenquduyishen decoction treatment", J Ethnopharmacol, 131(3), pp.581~584 (2010)
  14. NECA’s Guidance for Undertaking Systematic Reviews and Meta-analyses for Intervention, "Kim SY", National Evidence-based Health care Collaborating Agency, 1~287 (2011)
  15. 이준영, "메타분석", Endocrinology and Metabolism, 23(6), pp.361~378 (2008), 대한내분비학회
  16. Shi WW, "Clinical study on the treatment for chronic glomerulonephritis with Liuwei dihuang decoction", The Journal of Practical Medicine, 29(8), pp.1352~1354 (2013)
  17. Xu B, "Clinical Observation on Treatment of Chronic Glomerulonephritis with Modified Liuwei Dihuang Decoction", Clinical Journal of Traditional Chinese Medicine, 25(9), pp.775~776 (2013)
  18. Cen WX, "43 cases of chronic glomerulonephritis treated with Liuwei Dihuang Decoction and Zhuling Decoction on the basis of conventional therapy", Guangming Journal of Chinese Medicine, 29(4), pp.733~734 (2014)
  19. Yan ZY, "Adjuvant treatment of 41 cases of chronic glomerulonephritis with Liuwei Dihuang decoction", Clinical Research and Practice, 1(4), pp.59~ (2016)
  20. Huang RS, "Clinical Observation of Integrated Chines-Western Therapy to Cule Urine Occult Blood in Treatment of Chronic Glomerulonephritis", Chinese Journal of Ethnomedicine and Ethnopharmac, 25(20), pp.120~122 (2016)
  21. Wang Y, "Clinical Observation of Modified Liuwei Dihuang Decoction in Treating Chronic Glomerulonephritis", Nei Mongol Journal of Traditional Chinese Medicine, 7(13), pp.11~12 (2017)
  22. Zhang JW, "Clinical effect of Liuwei Dihuang decoction on chronic glomerulonephritis", China’s Naturopathy, 25(12), pp.45~46 (2017)
  23. Li W, "Clinical effect of Liuwei Dihuang decoction on chronic glomerulonephritis", Feet and Health, 11(193), pp.171~ (2018)
  24. Hu DQ, "Observation on the curative effect of traditional Chinese medicine Liuwei Dihuang decoction combined with western medicine in the treatment of chronic glomerulonephritis with kidney yin deficiency", Capital Food Medicine, 7(13), pp.184~185 (2020)
  25. Chen Y, "Effect of Liuwei Dihuang Decoction on Chronic Glomerulonephritis and Evaluation of TCM Syndrome", Score Chinese and Foreign Medical Research, 18(34), pp.161~163 (2020)
  26. Zhu DL, "Clinical Observation of Modified Liuwei Dihuang Decoction in Treating Chronic Glomerulonephritis", The Medical Forum, 25(2), pp.256~257 (2021)
  27. Zhou WD, "Clinical Observation on Buzhong Yiqi Decoction and Liuwei Dihuang Decoction in the Treatment of Chronic Glomerulonephritis", Guangming Journal of Chinese Medicine, 36(11), pp.1805~1807 (2021)
  28. "Evidence -based Guidline for Chronic Kidney Disease in Primary care 2022" (2022)[URL]
  29. Wang YJ, "Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3 : a multicenter double-blinded randomized controlled trial", J Ethnopharmacol, 139(3), pp.757~764 (2012)
  30. 김창석, "한양방 병용치료에 대한 문헌고찰", 한국한의학연구원논문집, 18(2), pp.101~116 (2012), 한국한의학연구원
  31. 정종진, "IgA 신증에 의한 말기 신질환에 대한 증례보고", 동의생리병리학회지, 27(6), pp.823~826 (2013), 한의병리학회
  32. Zhong Y, "Recent Advances in Traditional Chinese Medicine for Kidney Disease", Am J Kidney Dis, 66(3), pp.513~522 (2015)
  33. Lee JD, "Oriental pathology through 30 prescription", pp.800~807 (2015), Jeongdam
  34. Kang DG, "Yukmijihwang-tang ameliorates ischemia", reperfusion-induced renal injury in rats, 2006, pp.104(1), 47~53
  35. Cho WJ, "A study on the effect of Yukmijiwhangtang aqua-aqupuncture on the nephrotoxicity of cyclosporin A", The journal of korean acupuncture & moxibustion society, 13(2), pp.212~225 (1996)
  36. Zhou Y, "Comparison of Antioxidant Effect of Rehmannia glutinosa Decoction Pieces and Its Polysaccharides on Aging Model Rats before and after Processing Based on the Characteristic Ancient Method", China Pharmacy, 31(17), pp.2087~2093 (2020)
  37. Huang L, "Effects of Rhizoma dioscorea polysaccharide on renal function and CMP-1 expression in kidney of diabetic nephropathy rats", China Tropical Medicine, 13(12), pp.1456~1459 (2013)
  38. Qin Y, "An influence of rhizoma alismatis on Wistar chronic kidney function exhaustion", Journal of Changchun University, 13(3), pp.18~19 (2003)
  39. Zhang M, "The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats", Oxidative Medicine and Cellular Longevity, 2014(1), pp.1~12 (2014)
  40. Li HJ, "ffects of Water Extract of Poria Cocos on Renal Function in Kidney-yang Deficiency and Edema Rats", China Pharmacist, 25(4), pp.578~583 (2022)
  41. Yang Li, "Aristolochic acid nephropathy : variation in presentation and prognosis", Nephrol Dial Transplant, 27(1), pp.292~298 (2012)
  42. 박경아, "이뇨제 복용 중 소량의 감초 복용 후 발생한 저칼륨혈증성 횡문근 융해증 1예", 대한내과학회지, 80, pp.258~262 (2011), 대한내과학회
  43. Hsieh CF, "Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease : results from a population-based follow-up study", BMJ Open, 4(2), pp.e004033~ (2014)
  44. 김보민, "일차성 사구체신염에 대한 저령탕 병용요법의 효능 : 체계적 문헌고찰 및 메타 분석", 대한한방내과학회지, 41(4), pp.644~657 (2020), 대한한방내과학회[DOI]
  45. 김동웅, "상용 한약복합 처방의 장기간 연용 투여가 당뇨병성 신증 및 만성 신부전 환자의 신기능에 미치는 영향", 동의생리병리학회지, 18(4), pp.1207~1212 (2004), 한의병리학회
  46. 전원경, "六味地黃湯의 마우스에 대한 급성독성", 대한한의학 방제학회지, 17(2), pp.65~72 (2009), 대한한의학방제학회

관련 논문AI추천

일차성 사구체신염에 대한 저령탕 병용요법의 효능 : 체계적 문헌고찰 및 메타 분석김보민, 조희근대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제4호만성신부전에 대한 한약 치료의 효과: 체계적 문헌 고찰 및 메타분석신길조, 정우령, 홍수화대한한방내과학회 · 대한한방내과학회지2024 · 제45권 제4호소아 IgA 신병증의 한약 치료에 대한 임상연구 동향정민정, 정지은대한한방소아과학회 · 대한한방소아과학회지2022 · 제36권 제3호소아의 난치성 신증후군의 한약 치료에 대한 최신 임상연구 동향김장현, 민상연, 장은하대한한방소아과학회 · 대한한방소아과학회지2020 · 제34권 제3호육미지황탕 가미방 투여로 호전된 소아 재발성 혈뇨 1례박은정, 이선정대한한방소아과학회 · 대한한방소아과학회지2017 · 제31권 제2호EBM 구축을 위한 육미지황탕 문헌 분석 연구서창섭, 신현규, 이남헌, 이준경, 이호영, 정다영, 최지윤, 하혜경한의병리학회 · 동의생리병리학회지2009 · 제23권 제1호

이 간행물의 다른 논문 (5건)

MARS-PD: Meridian Activation Remedy System for Parkinson’s Disease김찬영, 박상수, 최인우, 유호룡, 허왕정, 채인철, 박미소pp. 1-11네트워크 분석을 통한 東醫寶鑑 內傷문과 虛勞문의 처방 구성 본초 비교고흥, 신선미, 곽건신pp. 35-52유방암 환자의 Tamoxifen 복용 후유증에 대한 한방치료 2례황우석, 양정민, 오지훈, 양재우pp. 53-65뇌경색 후 발생한 자율신경 장애에 대해 심박변이도로 살펴본 분심기음의 효과 증례보고 1례강지현, 김준석, 장우석, 김나연, 김채은, 김서현pp. 66-76보행장애와 치매를 주소로 하는 외상 후 수두증 환자의 한의 복합치료 1례문병순, 전혜수, 정솔, 박정림, 윤종민, 황지현, 진효원pp. 77-85
원문 보기